- Profile
- Personal Information
- Publications
Experts in Pharmaceutical Sciences
Rabaa M. Al-Rousan Hamed I. Aly Daniela Z. Bazan Adam Brown Wei Minjie Juan F. Castro Dr. Manoj Kumar Barthwal Dr Jagavelu Kumaravelu Zakaria Abd Elmageed Burton M Altura BENJAMIN E. BLASS Charlotte Farris Michael Borenstein prof. dr. A.J.R. Heck Vibha Rani Reza Fassihi Shweta Dang MARC ILIES Adriana Ribeiro Silva SWATI NAGAR View MoreTom Bradley
Non-Executive Director
Pharmaceuticals
Oxford BioTherapeutics
Switzerland
Tom Bradley leads the growth capital team at Oxford Capital with responsibility for all investment and portfolio activities. He has over 15 years of venture and growth capital experience. Prior to Oxford Capital, Mr Bradley was a Partner at DN Capital, a leading early stage software and internet investor with offices in London and Menlo Park. While at DN Capital he led investments in companies such as Performance Horizon Group, Airsense Wireless, VouchedFor.co.uk, Lovespace, Brisk.io and Mister Spex. Mr Bradley also worked closely with leading businesses such as Shazam and Windeln.de. Earlier in his career, Mr Bradley was a Founder Partner of DFJ Esprit as part of the team that spun out of Cazenove. During that time he was instrumental in investments such as LOVEFILM (sold to Amazon) and Neteconomy (sold to Fiserv). He spent his early career at SOFTBANK Capital and Datamonitor. Mr Bradley holds an MA in Modern History from Oxford University where he studied at Brasenose College.
Genetics